Your partner in Medicinal Chemistry and Life Sciences R&D

OXELTIS is an independent medicinal chemistry oriented service company that provides competencies and resources necessary for the success of your projects involving medicinal and fine organic chemistry in the fields of pharmaceutical, diagnostic and academic research.

Oxeltis labs and office are open as normal during COVID-19 pandemic.

With the objective of accelerating hit and lead discovery and optimization processes in the pharma and biopharma industry, Oxeltis brings to its customers and partners research strengths and expertise in nucleosides, nucleotides, heterocyclic, macrocyclic, mono & oligo/polysaccharides, phosphorus and fluorine chemistry applied to drug discovery.

The Oxeltis Team is also active in applying its fine organic chemistry expertise to the development of diagnostic and research tools.


37th ACS Medicinal chemistry symposium June 26-29th, 2022

Oxeltis will be present at the 37th ACS National Medicinal Chemistry Symposium in NY June (…)
See more

Lead Pharma and oxeltis receive €800K Eureka euristars grant

Grant will fund three-year EPIGENEXT joint project aimed at developing first-in-class therapy for diffuse large (…)
See more